Results 1 to 10 of about 25,771 (163)

Atrophic hypothyroidism associated with thyrotropin receptor antibodies [PDF]

open access: yesEinstein (São Paulo)
Hypothyroidism is most frequently caused by Hashimoto's thyroiditis. While thyrotropin receptor antibodies are well-known in Graves’ disease-induced hyperthyroidism, their role in hypothyroidism is emerging. We report the case of a 37-year-old woman with
Marcos Tadashi Kakitani Toyoshima   +5 more
doaj   +2 more sources

Ambient biothermal stress, preconceptional thyrotropin abnormalities, and the risk of preterm birth: a nationwide Chinese cohort study [PDF]

open access: yesNature Communications
Epidemiologic evidence on thermal stress and preterm birth (PTB) is based on ambient temperature rather than a biothermal metric. Thyrotropin abnormalities have been associated with PTB and may increase thermal vulnerability.
Xinghou He   +18 more
doaj   +2 more sources

Role of the thyrotropin-releasing hormone of the limbic system in mood and eating regulation

open access: yesJournal of Integrative Neuroscience, 2022
Thyrotropin-releasing hormone (TRH) and its receptors are expressed in the hypothalamus and limbic regions. Brain thyrotropin-releasing hormone actions are exerted directly through its receptors and indirectly by modulating the effects of ...
Elena Alvarez-Salas   +3 more
doaj   +1 more source

Thyroid Hormone Reference Intervals among Healthy Individuals In Lanzhou, China [PDF]

open access: yesEndocrinology and Metabolism, 2023
Background The common reference intervals (RIs) for thyroid hormones currently used in China are provided by equipment manufacturers. This study aimed to establish thyroid hormone RIs in the population of Lanzhou, a city in the subplateau region of ...
Yan Lu   +6 more
doaj   +1 more source

A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol [PDF]

open access: yesEndocrinology and Metabolism, 2021
Background Postoperative thyroid stimulating hormone (TSH) suppression therapy is recommended for patients with intermediate- and high-risk differentiated thyroid cancer to prevent the recurrence of thyroid cancer.
Eun Kyung Lee   +29 more
doaj   +1 more source

Risk Factors for Delayed Hyperthyrotropinemia in Late Preterm Infants [PDF]

open access: yesNeonatal Medicine, 2019
Purpose This study aimed to investigate the prevalence of delayed thyroid dysfunction based on iodine disinfectant use and to analyze associated risk factors.
Mun Hui Jeong   +5 more
doaj   +1 more source

An elevated parametric thyroid feedback quantile-based index is associated with atrial fibrillation

open access: yesFrontiers in Endocrinology, 2023
IntroductionAtrial fibrillation is associated with hyperthyroidism. Within the euthyroid range, it is also associated with high thyroxine (fT4), but not with thyrotropin (TSH).
Vanesa Alonso-Ventura   +36 more
doaj   +1 more source

The Recovery of Thyroid Function in Low-Risk Papillary Thyroid Cancer After Lobectomy: A 3-Year Follow-Up Study

open access: yesFrontiers in Endocrinology, 2021
PurposeManagement strategies after lobectomy for low-risk papillary thyroid carcinoma (PTC) are controversial. This study aimed to identify the proportion of patients among low-risk PTC patients who do not require hormone replacement therapy and to ...
Yi Dou   +3 more
doaj   +1 more source

Prevalence and complications of subclinical and overt hypothyroidism in pregnancy at North Indian tertiary care center

open access: yesIndian Journal of Community Medicine, 2023
Background: Thyroid disorders are one of the commonest endocrine problems among pregnant women. It is often argued that it is not only overt, but subclinical thyroid dysfunction also has similar adverse effects on maternal and fetal outcomes.
Prabhat   +4 more
doaj   +1 more source

Secondary amenorrhea in a woman with spinocerebellar degeneration treated with thyrotropin-releasing hormone: a case report and in vitro analysis

open access: yesJournal of Medical Case Reports, 2011
Introduction While thyrotropin-releasing hormone is known to be a prolactin-release stimulating factor, thyrotropin-releasing hormone-tartrate and its derivative, taltirelin hydrate, are used for the treatment of spinocerebellar degeneration, a ...
Kanasaki Haruhiko   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy